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Background: Leishmania infantum is the main etiological agent of both visceral and cutaneous clinical forms of
leishmaniasis in the Mediterranean area. Leishmania/HIV coinfection in this area is characterized by a chronic course
and frequent recurrences of clinical episodes. The present study using Multilocus Microsatellite Typing (MLMT)
analysis, a highly discriminative tool, aimed to genetically characterize L. infantum isolates taken from monitored
Leishmania/HIV coinfected patients presenting successive clinical episodes.
Methods: In this study, by the analysis of 20 microsatellite loci, we studied the MLMT profiles of 25 L. infantum isolates
from 8 Leishmania/HIV coinfected patients who had experienced several clinical episodes. Two to seven isolates per
patient were taken before and after treatment, during clinical and non-clinical episodes, with time intervals of 6 days to
29 months. Genetic diversity, clustering and phenetic analyses were performed.
Results: MLMT enabled us to study the genetic characteristics of the 25 L. infantum isolates, differentiating 18
genotypes, corresponding to a genotypic diversity of 0.72. Fifteen genotypes were unique in the total sample set and
only 3 were repeated, 2 of which were detected in different patients. Both clustering and phylogenetic analyses
provided insights into the genetic links between the isolates; in five patients isolates showed clear genetic links: either
the genotype was exactly the same or only slightly different. In contrast, the isolates of the other three patients were
dispersed in different clusters and some could be the result of mixing between populations.
Conclusions: Our data indicated a great MLMT variability between isolates from coinfected patients and no
predominant genotype was observed. Despite this, almost all clinical episodes could be interpreted as a relapse rather
than a reinfection. The results showed that diverse factors like an intrapatient evolution over time or culture bias could
influence the parasite population detected in the patient, making it difficult to differentiate between relapse and
reinfection.
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The first case of leishmaniasis associated with HIV infec-
tion was reported in 1985. Since then, cases of coinfec-
tion have been reported in 35 countries around the
world, with an increasing number occurring in southern
Europe. The four European countries most affected are
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creativecommons.org/publicdomain/zero/1.0/having the highest incidence due to a greater geographical
overlap between leishmaniasis and HIV infections [1].
Leishmania infantum is the main etiological agent of both
visceral and cutaneous clinical forms of human leishman-
iasis in this area, which is transmitted through vectors of
the species Phlebotomus perniciosus and P. ariasi [2].
These cases of leishmaniasis/HIV coinfection usually re-
sult in visceral leishmaniasis (VL), and are often thought
to be related to the reactivation of asymptomatic infec-
tions [1]. Acquired infection among intravenous drug
users (IVDU) sharing contaminated syringes has also beencess article distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in any
ly credited. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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[3]. VL cases associated with HIV are characterized by the
appearance of numerous recurrences of clinical episodes
that vary in number and average duration according to
the immunological status of patients, parasite species, and
use of anti-leishmanial therapy [1].
For the epidemiological study and follow-up of these
coinfection cases, highly discriminatory methods are
needed to differentiate Leishmania at the strain level
[4, 5]. Previous research on different Leishmania
strains of coinfected patients in France using isoenzy-
matic characterization (MLEE) revealed a low poly-
morphism in primo infection as well as in relapse
cases [6]. Research performed in Catalonia, our area
of study, has also registered a low polymorphism
among coinfected patients, with more than 50 % of
the studied strains belonging to zymodeme MON-1
[7]; in the south of Spain, however, a greater poly-
morphism was found by MLEE studies, although al-
most 50 % of strains were described as zymodeme
MON-1 [8, 9].
Microsatellite markers have proved to be powerful
tools for molecular typing and population genetic studies
in Leishmania, being able to discriminate among zymo-
demes, even within MON-1 [4]. Microsatellites are short
nucleotide fragments of 1 to 6 bp repeated in tandem
and ubiquitously distributed in the genomes of
eukaryotic organisms [10]. They present high rates of
mutation and variability due to allelic repeat length vari-
ation [11, 12]. The Multilocus Microsatellite Typing
(MLMT) approach developed for the Leishmania dono-
vani complex is based on a set of 14–20 unlinked micro-
satellite loci [12]. The present MLMT study aimed to
genetically characterize L. infantum isolates taken from
monitored Leishmania/HIV coinfected patients present-
ing subsequent clinical episodes. The specific objective
was to define the genetic links between the parasites of
VL patients under study, and between parasites from re-
peated isolates from the same patient. Besides describing
a Leishmania population in HIV patients, this genetic
study attempted to generate data that would help to dif-
ferentiate between parasite reinfections and relapses.
Methods
Patients
The study included 8 adults (7 men and 1 woman) with
Leishmania/HIV coinfection from the Barcelona metro-
politan area, monitored at the Hospital Vall d’Hebron
(Barcelona, Spain). Six patients were IVDU, aged from
27 to 44 years at the start of the study, when the first
Leishmania isolate was obtained (Table 1).
All patients were under HAART therapy (Highly
Active AntiRetroviral Therapy). Diagnosis of VL was
confirmed by culture in bone marrow or peripheralblood. After diagnosis, patients received one of the
following treatments at standard doses: liposomal
amphotericin B or amphotericin B lipid complex.
Ethical approval
The study protocol was approved by the institutional re-
view board of the hospital, and all patients signed in-
formed consent for their participation in this study.
Leishmania isolates
Twenty-five isolates were obtained from clinical and
non-clinical episodes of the 8 patients. Two to seven iso-
lates per patient were taken before and after treatment,
with time intervals of 6 days to 29 months (Table 1).
Eighteen isolates were obtained during clinical episodes
and seven during non-clinical episodes. “In vitro” culture
was performed using NNN (Novy-McNeal-Nicolle’s)
medium and/or Schneider's insect culture medium
(Sigma, St. Louis, MO) supplemented with 20 % heat-
inactivated fetal calf serum, 1 % sterile human urine, and
25 μg/mL gentamicin solution. Cultures were main-
tained between 24 °C and 26 °C, examined twice a week,
and sub-cultured every 2 weeks for 6 months before be-
ing considered negative. All isolates were stored in the
Leishmania Cryobank at the Universitat de Barcelona.
A L. infantum strain from Toulouse (France) was
used as a reference to build the neighbor-joining (NJ)
tree: LEM2355 (WHO code: MHOM/FR/91/LEM2355;
MON-183).
DNA extraction
One cryovial from each isolate was used for isolation of
DNA. The promastigotes were quickly thawed and DNA
was extracted using a chelex resin protocol: 100 μL of
sterile water and 400 μL of chelex solution [1 % Tween
20 (Sigma, St. Louis, MO), 1 % Nonidet P-40 (Sigma, St.
Louis, MO) and 20 % of chelex resin (BioRad Laborator-
ies, Hercules, CA)] were added to the promastigote sedi-
ment. It was heated at 100 °C for 20 min and then
vortexed. Finally, the mixture was centrifuged for
10 min at 12,000 g to separate the resin and the super-
natant was collected as the substrate for the PCR, either
performed immediately or after storage at −20 °C. All
isolates were confirmed as L. infantum by specific PCR
[13, 14].
Multilocus Microsatellite Typing (MLMT)
The genotyping was done using 20 microsatellite markers
previously described for the genetic characterization of
L. infantum (Table 2). Amplification was performed
in a volume of 30 μL containing 3 μL of 10X buffer,
1 nmol of dNTP mix, and 10 pmol of each primer
(the forward being labeled) and 1.5 units of Taq polymer-
ase (Taq Polymerase, 5U/μL, Roche Diagnostics, France).
Table 1 Identification of the 25 Leishmania isolates used in this study from 8 Leishmania/HIV coinfected patients obtained during
VL clinical episodes or non-clinical episodes, from bone marrow or peripheral blood mononuclear cell samples; and their genotyping
and clustering analysis results
Patient
code
Patient
isolates
Sex Age Risk
factor
Time from first
episode (in months)
Clinical
status
Sample
Type
WHO Code Genotype
(G)
Cluster
(C)
P1 1a Man 30 IVDU June CE PBMC MHOM/ES/00/BCN-
278
G14 C2b
1b 8 m CE PBMC MHOM/ES/01/BCN-
376
G13 C2b
1c 20 m CE PBMC MHOM/ES/02/BCN-
464
G15 C2b
P2 2a Man 44 IVDU July CE BM MHOM/ES/00/BCN-
284
G3 C1
2b 2 m CE BM MHOM/ES/00/BCN-
289
G2 C1
P3 3a Man 36 nd May CE BM MHOM/ES/01/BCN-
404
G16 C2
3b 7 m NE PBMC MHOM/ES/01/BCN-
455
G16 C2
3c 12 m CE BM MHOM/ES/02/BCN-
492
G16 C2
P4 4a Man 34 IVDU April CE BM MHOM/ES/02/BCN-
475
G9 C2
4b 6 m CE BM MHOM/ES/02/BCN-
508
G9 C2
P5 5a Man 36 IVDU September CE BM MHOM/ES/94/BCN-
123
G10 C2
5b 5 m CE BM MHOM/ES/95/BCN-
130
G1 -
P6 6a Man 33 IVDU October CE BM MHOM/ES/00/BCN-
298
G11 C2
6b 6 m CE BM MHOM/ES/01/BCN-
400
G5 C2
6c 17 m CE BM MHOM/ES/02/BCN-
470
G12 C2
P7 7a Man 41 nd October CE PBMC MHOM/ES/01/BCN-
430
G7 C2a
7b 3 m NE BM MHOM/ES/02/BCN-
460
G7 C2a
7c 4 m CE PBMC MHOM/ES/02/BCN-
472
G6 C2a
P8 8a Woman 27 IVDU October CE PBMC MHOM/ES/00/BCN-
293
G4 C2
8b 1 m NE PBMC MHOM/ES/00/BCN-
306
G7 C2a
8c 1 m + 6 days NE PBMC MHOM/ES/01/BCN-
307
G8 C2
8d 3 m NE PBMC MHOM/ES/01/BCN-
369
G16 C2
8e 7 m CE PBMC MHOM/ES/01/BCN-
405
G18 C2
8f 9 m NE PBMC MHOM/ES/01/BCN-
422
G17 C2
8 g 29 m NE PBMC MHOM/ES/03/BCN-
561
G16 C2
IVDU intravenous drug user, nd not determined, CE clinical episode, NE non-clinical episode, PBMC peripheral blood mononuclear cell, BM bone marrow
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Table 2 Characteristics of the 20 microsatellite loci used in this study for Leishmania infantum genotyping
Locus GenBank accession no. Allele size (bp) Dye label Ta (°C) Na HS Ho
Li22-35c AM050045 90–106 VIC 58 5 0.191 0.042
Li45-24c AM050048 88–108 NED 58 5 0.208 0.060
Li71-5/2c AM050050 104–108 VIC 54 3 0.280 0.042
Li72-20c AM050057 87–95 VIC 50 4 0.275 0.042
LiBTAa nd 226–246 VIC 58 4 0.316 0.167
LiBTGa nd 219–257 6-FAM 58 7 0.340 0.104
LIST7021b AF427869 228–246 6-FAM 54 6 0.338 0.143
LIST7024b AF427872 198–224 VIC 59 3 0.049 0.000
LIST7025b AF427873 171–179 6-FAM 56 1 0.000 0.000
LIST7026b AF427874 201–231 NED 56 4 0.089 0.000
LIST7028b AF427876 104–108 VIC 58 2 0.049 0.000
LIST7031b AF427879 166–174 PET 54 1 0.000 0.000
LIST7033b AF427881 196–226 6-FAM 58 5 0.349 0.411
LIST7035b AF427883 188–202 PET 56 6 0.373 0.146
LIST7037b AF427885 178–194 6-FAM 58 5 0.320 0.411
LIST7038b AF427886 122–130 NED 56 3 0.088 0.000
LIST7039b AF427887 199–215 PET 58 5 0.128 0.143
Rossi1d X76394 104–110 6-FAM 59 3 0.100 0.000
Rossi2d X76393 140–160 VIC 57 6 0.335 0.185
TubCAc nd 74–84 6-FAM 58 2 0.100 0.000
Mean value 4 0.196 0.095
Ta: annealing temperature (thermocycling conditions); Na: number of alleles; Hs: Nei’s unbiased genetic diversity within subsamples; Ho: observed heterozygosity
(Nei & Chesser, 1983 [17]); aBulle, 2002 [32]; Hide, 2013 [24]; bJamjoon, 2002 [33]; cOchsenreither, 2006 [11]; dRossi, 1994 [34]
Tomás-Pérez et al. Parasites & Vectors  (2015) 8:386 Page 4 of 9We added 50 ng of extracted DNA to the mixture
and incubated it in a thermal cycler under the follow-
ing conditions: a denaturing step at 94 °C for 2 min,
followed by 35 cycles of denaturation for 30 s at 94 °C,
annealing for 1 min at the annealing temperature of each
locus (Table 2) and extension for 1 min at 72 °C, followed
by a final extension at 72 °C for 30 min. The amplified
products were analyzed using an automated fragment
analysis on an ABI Prism 3130XL genetic analyzer
(Applied Biosystems, France) with a Genescan 500
LIZ internal size standard. Finally, data were analyzed
with GeneMapper analysis software (version 4.0, Applied
Biosystems, France).Genetic diversity and differentiation analysis
Data were analyzed with FSTAT Version 2.9.3.2 [15]
updated from [16], which allows the calculation of di-
versity indices such as Nei’s unbiased genetic diversity
index within sub-samples (Hs), the observed heterozy-
gosity (Ho), as a measure of genetic diversity [17],
and the number of alleles per locus (Na) measuring
genetic polymorphism. The genotypic diversity was
calculated as the ratio of the number of genotypes
per total number of samples.Clustering and phenetic analyses
The genetic characteristics of the Leishmania samples
under study were investigated with MLMT data by two
different methods. The first was based on genetic
distances by the construction of a phenetic tree ac-
cording to the proportion of shared allele dis-
tances (DAS). The Neighbor-Joining (NJ) tree [18] was
constructed through calculations of Cavalli-Sforza gen-
etic distance from allelic frequencies, and the robustness
of tree topology was obtained by bootstrap resam-
pling of loci, with 100 replications per set. We used
PHYLIP software (3.67 package; J. Felsenstein, 1993.
Department of Genetics, University of Washington,
Seattle, USA) and the tree was edited and visualized
with TreeDyn software [19]. The second approach
consisted of a model-based Bayesian clustering method
implemented in STRUCTURE v 2.3.1 [20]. This algo-
rithm simultaneously estimates the allele frequencies to
assign individuals into genetically distinct populations
(K) and each probability for the identification of the
most likely number of populations. The allele frequen-
cies among populations were correlated by admixture
modeling for a series of runs using a ‘burn-in’ period of
20,000 iterations and probability estimates based on
200,000 of Markov chain Monte Carlo (MCMC) repeats.
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each possible number of clusters (K) in order to quantify
the variation in the likelihood of the data for a given K.
The most appropriate number of populations was deter-
mined based upon ad hoc statistic ΔK, which evaluates
the second order rate of change of the likelihood func-
tion with respect to the number of populations (K).
Results
Genetic diversity
All 20 microsatellite loci used for the analysis of the 25
L. infantum isolates produced clear electrophoregrams,
with only one or two alleles at each locus. We found 18
polymorphic microsatellite markers, with LiBTG as the
most polymorphic, having 7 different alleles (Na) and
two monomorphic markers, LIST7025 and LIST7031.
We observed 8 polymorphic microsatellites with more
than 5 alleles, LIST7021, LIST7035 and Rossi2 with 6 al-
leles each; and Li22-35, Li45-24, LIST7033, LIST7037
and LIST7039 with 5 alleles. Markers Li72-20, LiBTA
and LIST7026 revealed 4 alleles; Li71-5/2, LIST7024,
Rossi1 and LIST7038 3 alleles; TubCA and LIST7028
showed 2 alleles. The mean value was 4 alleles per locus
(Table 2). The diversity analysis, including all the 25 iso-
lates, revealed an observed heterozygosity (Ho) between
0 and 0.411 (overall 0.095); the mean intrapopulation
genetic diversity (Hs) ranged between 0 and 0.373, with
an overall value of 0.196 (Table 2).
Genotype analysis and phylogenetic reconstruction
A total of 18 genotypes (G) were characterized for the
25 isolates belonging to the 8 monitored patients
(Table 1), corresponding to a genotypic diversity of 0.72.
Of these genotypes, 15 were unique in the total sample
set, and only 3 (G7, G9 and G16) were repeated. The
three repeated genotypes were found in four different
patients: G7 in two of the three isolates of patient P7
and one of the seven isolates of patient P8; G9 in the
two isolates of patient P4; and G16 in the three isolates
of patient P3 and two isolates of patient P8. Only geno-
types G16 and G7 were detected in two different
patients.
MLMT profiles were used to calculate genetic dis-
tances and build a neighbor-joining tree. The genetic
distance tree allowed us to differentiate 2 main popula-
tions or clusters C1 and C2, the latter composed of 2
well-supported sub-clusters C2a and C2b (Fig. 1). The
reference strain LEM2355 was used as the outgroup. At
the top of the tree, isolate 5b from patient P5 is clearly
separated from the others. The first cluster (C1) is com-
posed of the two isolates obtained from patient P2, sepa-
rated from the others with a strong bootstrap value of
100 %. The second cluster (C2) is defined by a bootstrap
value of 84 % and contains all the other 22 isolates. InC2 we can detect several sub-clusters, but only two,
representing 5 samples and designated as C2a and C2b,
are supported by bootstrap values higher than 80 %.
C2a, with a bootstrap value of 100 %, is composed of the
three isolates of patient P7 and one isolate (8b) of pa-
tient P8; C2b is supported by a bootstrap value of 84 %
and includes all isolates from patient P1.
Clustering analysis
The population organization of the 25 isolates was
analyzed with STRUCTURE software for a better
visualization of the data. Using the methods of
Evanno and Garnier [21, 22], the analysis indicated
the existence of 6 different populations (K = 6) (Figs. 1
and 2). Considering K = 6, all isolates from patients
P2 and P1 defined two of these six populations, cor-
responding to the cluster C1 and the sub-cluster C2b
of the phenetic tree. A third STRUCTURE population
was defined by all isolates from patient P7 and one
isolate from patient P8 (8b), corresponding to the
sub-cluster C2a. A fourth population included all
other isolates from C2, which were all isolates from
patients P3 and P4, and some isolates belonging to
patients P5, P6 and P8 (5a, 6a, 6c, 8c, 8d, 8e, 8f and
8 g). The two other populations were defined by the
outgroup and one isolate from patient P5 (5b). The
STRUCTURE analysis did not allow the classification
of two isolates, 8a and 6b, which appear as mixed ge-
notypes of NJ tree populations, C2, C2a and the non-
classified isolate 5b from patient P5.
Discussion
L. infantum is the causative species of VL and CL in the
northwest Mediterranean area and an opportunistic
parasite in HIV patients. It appears that immunocom-
promised people may be vulnerable to parasites that
either fail to survive or never cause detectable mor-
bidity in immunocompetent people. Furthermore,
“dermotropic” variants of L. infantum have been re-
ported to cause visceral disease in HIV-positive pa-
tients [1, 8, 23]. Other studies have revealed
differences in parasitic genotypes between L. infantum
strains from asymptomatic carriers and HIV-positive
VL patients, suggesting that some genotypes do not
cause disease [24]. Greater knowledge about the intra-
specific variability of the Leishmania parasite from
HIV-positive VL patients may help to understand
some important key points, such as transmission pat-
terns, response to treatment and the importance of
immunity, and the parasite’s capacity to survive
within human hosts.
In the present study, MLMT characterization of 25
L. infantum isolates showed the existence of a genetic
polymorphism, with a mean number of alleles per
Fig. 1 Phylogenetic and clustering analysis of 25 L. infantum isolates from 8 Leishmania/HIV coinfected patients for the data of 20 microsatellite
markers. a Neighbor-joining tree inferred from the Cavalli-Sforza genetic distance results using PHYLIP and TreeDyn software for tree edition and
visualization. The bootstrap values above 50 % are shown. The Leishmania isolates number (in colors), genotypes (G1-G18), clusters (C1 and C2)
and sub-clusters (C2a and C2b) are indicated. b Populations identified by STRUCTURE (K = 6) divided in colors, organized according to the
neighbor-joining tree. Clusters and sub-clusters are also indicated
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from only 8 coinfected patients monitored over time,
from the restricted geographical area of Barcelona,
the Na is not negligible when compared with previous
studies performed in nearby areas. In the South of
France, a mean Na of 4.13 was found within L. infan-
tum isolates from symptomatic humans and dogs and
asymptomatic humans [24]. A similar mean Na value
of 4.57 was obtained in Portugal from human, dog,
vulpine and phlebotomine L. infantum isolates [25].
Likewise, another study performed on MON-1 L.
infantum isolates from human patients, dogs and
phlebotomine sand flies of Spain, Portugal and Greece
obtained a mean Na value of 4.6 [4].Furthermore, 18 different genotypes were found in
the 25 analyzed isolates, with a low number of re-
peated genotypes, despite their limited geographical
and human origin. Fifteen genotypes were unique in
the total sample set, and only three (G7, G9 and
G16) were repeated; both G7 and G16 appeared in
two different patients, and G9 in two isolates from
the same patient. No relationship was observed be-
tween genotypes and the clinical status of patients,
with 16 different genotypes among the 18 clinical epi-
sodes, and two (G7 and G16) of the three repeated
genotypes present in clinical and non-clinical epi-
sodes. The kind of sample used in the study, bone
marrow or peripheral blood, was not associated with
Fig. 2 Population structure of the 25 L. infantum isolates coming from Leishmania/HIV coinfected patients as inferred by STRUCTURE software
on the basis of 20 microsatellite data. The peak at K = 6 represents the most probable number of populations; vertical bars represent each
analyzed isolate divided into K colors. Each color represents one population, and the length of the colored segments shows the estimated proportion
of membership of the isolate in that population
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other authors [26].
Our data indicated a high degree of heterogeneity
and no predominant genotype in the isolates, but a
more extensive study is required to assess the real
variability and abundance of genotypes in immuno-
compromised patients in this area. The parasite het-
erogeneity observed in our patient set is in agreement
with the genetic variability described in a previous
MLMT study on Leishmania isolates from dogs and
sand flies performed in a rural leishmaniasis-endemic
area close to Barcelona (Priorat, Tarragona) [26].
Other MLMT studies performed on Leishmania para-
sites from different hosts, geographical regions and
clinical forms have also found a low number of re-
peated multilocus genotypes [25, 26]. A Portuguese
study reported a generally low percentage (12 %) of
repeated genotypes, although a higher percentage was
found in coinfected patients [25], which was related
to human-to-human transmission, notably associated
with IVDU [27, 28]. The genotypic diversity registered
in our study was 0.72, which is higher than in other
studies performed in Europe, for example, 0.55 in
Greece [29] or 0.67 in Portugal [25]. However, any
comparison between these results is limited by the
variable number of isolates and loci analyzed.
Leishmania/HIV coinfection is characterized by fre-
quent recurrences of clinical episodes. Previous studies
with monitored L. infantum/HIV coinfected patients in
our endemic area revealed the existence of a residual
parasite load, using qPCR analysis after patient treat-
ment, which has been related to the chronic course of
the disease and subsequent recurrences of VL [30]. It is
fair to assume that, in general, clinical recurrences
may be related to relapses produced by the same
parasite rather than reinfections. Nevertheless, detec-
tion by qPCR did not allow parasite characterization
to differentiate between a relapse and reinfection [30].
In contrast, the use of MLMT analysis has provenuseful in this respect and allowed to detect a high
percentage of relapse cases among the clinical epi-
sodes of coinfected patients [4, 5, 25]. In our study,
the phylogenetic reconstruction of our data by
neighbor-joining (NJ) tree and STRUCTURE analysis
was useful to visualize isolate distribution and genetic
relationships.
In five patients (P1, P2, P3, P4 and P7), the NJ tree
showed clear genetic links between the different iso-
lates; either the genotype was exactly the same or
slightly different. The isolates of two patients (P3 and
P4) shared the same genotype, showing that these
clinical episodes were due to the same Leishmania
genotype. In these two patients, clinical episodes oc-
curred 6 months after treatment and were not consid-
ered as a failure of treatment by clinicians. The close
genetic similarity of isolates from the other three pa-
tients (P1, P2 and P7) may be due to the evolution of
the Leishmania population in the patient under
pharmacological and/or immunological pressure, and
thus these cases could also be interpreted as a re-
lapse. This suggests that in some cases the Leish-
mania population underwent an intrapatient evolution
over time. In patients P2 and P7, this hypothesis is
supported by the short time between the end of the
treatment and the new clinical episode, which was
considered by clinicians as a therapeutic failure, un-
like the case of patient P1, with 8 and 12 months be-
tween clinical episodes.
The isolates of patients P5, P6 and P8, which showed a
high dispersion in the NJ tree, suggested another hypoth-
esis. The results obtained with STRUCTURE were glo-
bally in agreement with the genetic distance analysis,
clearly indicating that isolates from these three patients
correspond to different populations and some would be
the result of mixing between populations, such as the 6b
and 8a samples. These differences cannot be explained
only by reinfection events caused by sand fly transmission,
since no transmission period occurred between some
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of a primo infection with multiple genotypes that
were hidden by the culture. Nevertheless, the possible
inoculation of different Leishmania genotypes by one
or several sand flies does not rule out a reinfection
by multiple sharing of contaminated syringes between
IVDU.
The case of patient P8 is remarkable, with seven
isolates, two from clinical episodes and five from
non-clinical episodes, represented by 6 different and
distant genotypes. Two genetically distant isolates
were obtained with only a six-day interval, thus ruling
out a reinfection, especially as the patient was hospi-
talized. Furthermore, this patient developed a second
clinical episode, again with a different genotype. This
high genetic variability suggests a mixed infection,
with a genotype selection during the culture of the
samples. Culture bias is a considerable inconvenience for
the interpretation of results, as it is impossible to assess if
one genotype is more responsible than another for the
clinical episode. To avoid culture selection, it would be in-
teresting to work directly with clinical samples, as other
authors have done [31].
Conclusion
The use of multilocus microsatellite markers to analyze
isolates taken from Leishmania/HIV coinfected patients
allowed us to study the evolution of the infections.
According to the results and clinical data, we had three
different case types in our study: (i) two coinfected pa-
tients who relapsed, with the same genotypes in different
clinical episodes (25 %); (ii) three coinfected patients who
probably relapsed, with slightly different genotypes be-
tween clinical episodes due to the evolution of the parasite
population within the patient (37.5 %), and (iii) three coin-
fected patients infected by several distant genotypes in the
first clinical episode and a differential selection by the
parasite culture performed for the study, or infected over
time by non-vectorial transmission associated with IVDU
(37.5 %). Due to the chronic nature of leishmaniasis in
Leishmania/HIV coinfected patients and frequent clinical
episode recurrences, close follow-up is required. Our
study indicated a great MLMT variability between isolates
from patients but, despite this, almost all clinical episodes
could be interpreted as relapses.
The results obtained in this research have generated
different hypotheses about Leishmania parasite behav-
ior in coinfected patients. To explore these hypoth-
eses in more depth, a broader study is required, using
a higher number of stocks from coinfected patients
monitored over time and from different geographical
areas. This study also shows the value of parasite typ-
ing to provide new insights into the behavior of
Leishmania parasites in human.Competing interests
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